Rohnert P, Schmidt W, Emmerlich P, Goihl A, Wrenger S, Bank U, Nordhoff K, Tager M, Ansorge S, Reinhold D, Striggow F (2012) <br />Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia<br /><i>J Neuroinflammation</i> <b>9</b>: 44<br /><br />Ansorge S, Nordhoff K, Bank U, Heimburg A, Julius H, Breyer D, Thielitz A, Reinhold D, Tager M (2011) <br />Novel aspects of cellular action of dipeptidyl peptidase IV/CD26<br /><i>Biol Chem</i> <b>392</b>: 153<br /><br />Bank U, Heimburg A, Wohlfarth A, Koch G, Nordhoff K, Julius H, Helmuth M, Breyer D, Reinhold D, Tager M, Ansorge S (2011) <br />Outside or inside: role of the subcellular localization of DP4-like enzymes for substrate conversion and inhibitor effects<br /><i>Biol Chem</i> <b>392</b>: 169<br /><br />Reinhold D, Bank U, Entz D, Goihl A, Stoye D, Wrenger S, Brocke S, Thielitz A, Stefin S, Nordhoff K, Heimburg A, Tager M, Ansorge S (2011) <br />PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J mice<br /><i>Biol Chem</i> <b>392</b>: 233<br /><br />Ansorge S, Bank U, Heimburg A, Helmuth M, Koch G, Tadje J, Lendeckel U, Wolke C, Neubert K, Faust J, Fuchs P, Reinhold D, Thielitz A, Tager M (2009) <br />Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions<br /><i>Clinical Chemistry & Laboratory Medicine</i> <b>47</b>: 253<br /><br />Reinhold D, Goihl A, Wrenger S, Reinhold A, Kuhlmann UC, Faust J, Neubert K, Thielitz A, Brocke S, Tager M, Ansorge S, Bank U (2009) <br />Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice<br /><i>Clinical Chemistry & Laboratory Medicine</i> <b>47</b>: 268<br /><br />Bank U, Bohr UR, Reinhold D, Lendeckel U, Ansorge S, Malfertheiner P, Tager M (2008) <br />Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors<br /><i>Front Biosci</i> <b>13</b>: 3699<br /><br />Reinhold D, Bank U, Tager M, Ansorge S, Wrenger S, Thielitz A, Lendeckel U, Faust J, Neubert K, Brocke S (2008) <br />DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis<br /><i>Front Biosci</i> <b>13</b>: 2356<br /><br />Thielitz A, Ansorge S, Bank U, Tager M, Wrenger S, Gollnick H, Reinhold D (2008) <br />The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases<br /><i>Front Biosci</i> <b>13</b>: 2364<br /><br />Reinhold D, Biton A, Goihl A, Pieper S, Lendeckel U, Faust J, Neubert K, Bank U, Tager M, Ansorge S, Brocke S (2007) <br />Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses<br /><i>Annals of the New York Academy of Sciences</i> <b>1110</b>: 402<br /><br />Bank U, Heimburg A, Helmuth M, Stefin S, Lendeckel U, Reinhold D, Faust J, Fuchs P, Sens B, Neubert K, Tager M, Ansorge S (2006) <br />Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease<br /><i>Int Immunopharmacol</i> <b>6</b>: 1925<br /><br />Biton A, Bank U, Tager M, Ansorge S, Reinhold D, Lendeckel U, Brocke S (2006) <br />Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation<br /><i>Advances in Experimental Medicine & Biology</i> <b>575</b>: 177<br /><br />Reinhold D, Biton A, Pieper S, Lendeckel U, Faust J, Neubert K, Bank U, Tager M, Ansorge S, Brocke S (2006) <br />Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation<br /><i>Int Immunopharmacol</i> <b>6</b>: 1935<br /><br />